Table 2

Allelic frequencies (%) of recurrent variants in two JS and four non-JS cohorts

JSNon-JSP value‡
European JS (n~551)US JS (n~600)WES-Mondino (n=987)WES-OPBG (n=12 848)NIG* (n~1685)gnomAD† (n~1 25 000)
TMEM216 c.218G>T§0.362.160.05000.003p<0.00001
p<0.0001
TMEM237 c.52C>T¶0.1800.05000.006p<0.0001
ns
MKS1 c.1408–34_1408-6del**0.270.160.100.0200.06p<0.005
ns
MKS1 c.1476T>G0.730.0800.040.030.006p<0.00001
p<0.05
KIAA0586 c.428delG2.273.261.060.440.840.31p<0.00001
ns
KIAA0586 exons8-10 del††0.360.10n.a.n.a.n.a.n.a.- ns
KIAA0586 c.863_864delAA0.270.250000.003p<0.00001
ns
KIAA0586 c.1006C>T0.1800.050.00800.0008p<0.00001
ns
RPGRIP1L c.1843A>C0.550.3200.00400.006p<0.00001
ns
CC2D2A c.4667A>T0.911.320.050.060.030.02p<0.00001
ns
TMEM67 c.755T>C0.270.1600.0080.060.008p<0.00001
ns
  • *NIG: Network of Italian Genomes.

  • †gnomAD: genome aggregation database global frequencies (V.2.1.1). For the Ashkenazim and the Norther European/Finnish founder variants, the relative subpopulations have been excluded from gnomAD count to avoid an incorrect inflation of the control frequencies due to founder effect bias.

  • ‡Upper line European JS versus all controls; lower line: European JS versus US JS. P values were calculated using χ2 test (with Fisher’s correction for TMEM237 c.52C>T and KIAA0586 c.1006C>T).

  • §Ashkenazi Jewish founder variant.

  • ¶Hutterite founder variant.

  • **Finnish/Norther European founder variant.

  • ††Being a large deletion, AF (alternative frequency) from non-JS cohorts are not available (n.a., not applicable).

  • JS, Joubert syndrome.